











              
  
       




                  





       
                 
 
             
 
       
  
 
                  
          
  
                   
               









         
               
                     









          
               
 
 
                   
       
               
                                               
                     
          
                 
                                                                                
                                                                                                   
         
      
        
 
MALARIA CASE SURVEILLANCE REPORT
Department of Health and Human Services, Centers for Disease Control and Prevention 





  State Case No: .......................  CSID No................................  Case No: .........................

Patient name (last, first): 
Date of symptom onset of this attack (mm/dd/yyyy): ____/ ____/ _____ 
Age: _______ yrs. mos.  wks.  days (circle units)
Date of Birth: ____/ ____/ ________ 
Is patient pregnant?  Yes  No 





Physician name (last, first):  
Telephone Number: ( ) _________  –  ___________ 
Ethnicity:  
 Hispanic or Latino 
 Not Hispanic or
Latino 
Race (select one or more): 
American Indian/Alaska Native  
Native Hawaiian/Other Pacific Islander 
Black or African American   
Asian  White  Unknown 
Positive lab test result (check all that apply): 
Smear    PCR RDT No test done/unknown 
Species (check all that apply):  
Vivax Falciparum Malariae Ovale Not Determined 
Other species (specify) __________________ 
Parasitemia (%): _______________________ 
State/territory reporting this case: ___________________ 
County:   ___________________ 
Patient admitted to hospital: Yes  No  Unknown 
Hospital: _______________________________________ 
Date:  ____/ ____/ ________ Hospital record No.: ________ 
Laboratory name: 
Telephone Number: ( ) _________  –  ___________ 
Specimens being sent to CDC?  Yes  No  Unknown 
If yes:  Smears   Whole Blood  Other: _______________ 
Has the patient traveled or lived outside the U.S. during the past 2 years? Yes  No  If yes, specify:  
Country: 1. ________________ 2. _________________ 3. ___________________ 
Date returned/ arrived in U.S. (mm/dd/yyyy): ____/ ____/ ______ ____/ ____/ ________ ____/ ____/ ________ 
Duration in country yrs.  mos.  wks. days  (circle units) _________________ __________________ ___________________ 
Did patient reside in U.S. prior to most recent travel? Principal reason for travel from/ to U.S. for most recent trip: 
Yes






 Visiting friends/relatives 
 Airline/ship crew 
 Missionary or dependent
 Refugee/immigrant 
 Student/teacher
 Other: ____________ 
Unknown
Was malaria chemoprophylaxis taken?  Yes   No  Unknown
If yes, which drugs were taken?  Chloroquine   Mefloquine  Doxycycline  Primaquine   Atovaquone/proguanil




 Yes, missed no doses

 No, missed doses 

 Unknown 
If doses were missed, what was the reason? 
Forgot
 Didn’t think needed 
 Had a side effect (specify): ________________ 
Was advised by others to stop 
 Prematurely stopped taking once home 
 Other (specify): _________________________
 Unknown 
History of malaria in last 12 months (prior to this report)?
 Yes No Unknown
Date of previous illness: ____/ ____/ ________ 
If yes, species  (check all that apply): 
Vivax Falciparum Malariae Ovale
Not Determined Other (specify) _____________ 
Blood transfusion/organ transplant within last 12 months:  Yes No  Unknown   If yes, date: ____/ ____/ ________ 
Clinical  Cerebral malaria    ARDS   None Was illness fatal: Yes No  Unknown 
Complications:  Renal failure  Severe anemia(Hb<7)  Other : ____________ If yes, date of death : _____/____/_______
Therapy for this attack (check all that apply): 
 Chloroquine  Tetracycline  Doxycycline Mefloquine   Exchange transfusion Artesunate  Artemether/lumefantrine  Unknown 
Primaquine  Quinine  Quinidine Clindamycin Atovaquone/proguanil   Other (specify): ____________________________ 
Person submitting report:    Telephone No. : 
Affiliation: Date Submitted: __________/__________/_____________ 
For CDC Use Only.  Classification  Imported  Induced   Introduced  Congenital  Cryptic
Public reporting burden of this collection of information is estimated to average 15 minutes per response. An agency may not conduct or sponsor, and a person is not required to respond to, a collection
of information unless it displays a currently valid OMB control number. Please send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions
for reducing this burden, to CDC/ATSDR Reports Clearance Officer; 1600 Clifton Rd., NE (MS D-24); Atlanta, GA 30333; ATTN: PRA (0920-0009).
CDC 54.1 11/2011 (Front) OMB 0920-0009
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Physicians and other health care providers with questions about diagnosis and treatment of malaria cases 
can call CDC’s Malaria Hotline: 
- Monday – Friday, 9:00 am to 5 pm, EST: call 770-488-7788 or 855-856-4713 (Fax: 404-718-4815) 
- Off-hours, weekends, and federal holidays: call 770-488-7100 and ask to have the malaria clinician on call paged.
Information on malaria risk, prevention, and treatment is available at: 
CDC’s Malaria Web site http://www.cdc.gov/malaria
Part II (to be complete 4 weeks after treatment) 
Please list all prescription and over the counter medicines the patient had taken during the 2 weeks before starting their treatment for malaria. 
Please list all prescription and over the counter medicines the patient had taken during the 4 weeks after starting their treatment for malaria. 
Was the medicine for malaria treatment taken as prescribed? No, doses missed  Yes, no doses missed   Unknown 
Did all signs or symptoms of malaria resolve without any additional If yes, did the patient experience a recurrence of signs or symptoms of 
malaria treatment within 7 days after treatment start? malaria during the 4 weeks after starting malaria treatment?
 Yes No  Unknown Yes  No  Unknown 
Did the patient experience any adverse events within 4 weeks after receiving the malaria treatment?  Yes     No  Unknown 
(If Yes): Event description Relationship Time to Fatal?   Life-  Other
to treatment  Onset since  Threatening?  Seriousness?** 






* Suspected means that a causal relationship between the treatment and an adverse event is at least a reasonable possibility, i.e., the relationship cannot be ruled out. 
** A serious adverse event is defined as an event which is fatal or life-threatening, results in persistent or significant disability/incapacity, constitutes a congenital 
anomaly/birth defect, is medically significant (i.e., jeopardizes the patient or may require medical or surgical intervention), or requires inpatient hospitalization or 
prolongation of existing hospitalization.
